Cross-sectional study in human pancreas revealed a reduced expression of FKBP5 in β cells of T2D patients, indicating a FKBP5-inhibition-mediated pro-survival mechanism against the complex stresses in type 2 diabetic milieus. This evidence concerns the gene FKBP5 and type 2 diabetes mellitus.